Picture of AtriCure logo

ATRC AtriCure News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

AtriCure Inc expected to post a loss of 23 cents a share - Earnings Preview

* AtriCure Inc  ATRC.OQ   ATRC.O  is expected to show a rise
in
quarterly revenue when it reports  results on February 15 for
the period ending December 31 2023
    * The Mason Ohio-based  company is expected to report a
17.8% increase in revenue to $103.681 million from $88.03
million a year ago, according to the mean estimate from 9
analysts, based on LSEG data.The company's guidance on January 8
2024, for the period ended December 31, was for revenue of
$106.500 million.
    * ​LSEG's mean analyst estimate for AtriCure Inc is for a
loss
of 23 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for AtriCure
Inc is
$54.50​, above​ its last closing price of $33.52. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.31       -0.31      -0.20     Beat    35.8
 Jun. 30 2023  -0.29       -0.30      -0.11     Beat    62.8
 Mar. 31 2023  -0.34       -0.34      -0.23     Beat    32.1​
 Dec. 31 2022  -0.17       -0.18      -0.09     Beat    48.8
 ​​Sep.        -0.25       -0.25      -0.27     Missed  -6.8
 30 2022                                                
 Jun. 30 2022  -0.29       -0.29      -0.32     Missed  -9.3​
 Mar. 31 2022  -0.31       -0.32      -0.33     Missed  -3.2
 Dec. 31 2021  -0.29       -0.29      -0.30     Missed  -3.4
 This summary was machine generated February 13 at 22:33 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on AtriCure

See all news